[ad_1] FRANKFURT: Germany’s BioNTech, Pfizer’s partner on COVID-19 vaccines, cut its drug development budget for this year after quarterly revenues were hurt by a plunge in pandemic-related demand. Second-quarter revenue…
[ad_1] FRANKFURT: Germany’s BioNTech, Pfizer’s partner on COVID-19 vaccines, cut its drug development budget for this year after quarterly revenues were hurt by a plunge in pandemic-related demand. Second-quarter revenue…